Pharmacokinetics and pharmacodynamics of once-daily arbekacin during continuous venovenous hemodiafiltration in critically ill patients

Oka, 1986, Fundamental and clinical study on HBK, a new aminoglycoside in surgical field, Jpn J Chemother, 34, 575 Fillastre, 1987, Pharmacokinetics of habekacin in patients with renal insufficiency, Antimicrob Agents Chemother, 31, 575, 10.1128/AAC.31.4.575 Arakawa, 1989, Clinical study of aminoglycosides on renal dysfunction, Hinyokika Kiyo (Acta Urologica Japonica), 35, 697 Matsuo, 1997, Administration of aminoglycosides to hemodialysis patients immediately before dialysis: a new dosing modality, Antimicrob Agents Chemother, 41, 2597, 10.1128/AAC.41.12.2597 Kaneoka, 2005, The removal rates of vancomycin and arbekacin by various kinds of dialyzers, Jpn J Urol Surg, 18, 817 Okada, 2005, Medication design of arbekacin based on hemodialysis schedule, Jpn J Ther Drug Monit, 22, 27 Yamaoka, 1981, A pharmacokinetic analysis program (multi) for microcomputer, J Pharmacobiodyn, 4, 879, 10.1248/bpb1978.4.879 Robatel, 2003, Pharmacokinetics and dosage adaptation of meropenem during continuous venovenous hemodiafiltration in critically ill patients, J Clin Pharmacol, 43, 1329, 10.1177/0091270003260286 Giles, 2000, Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration, Crit Care Med, 28, 632, 10.1097/00003246-200003000-00005 Ikawa, 2008, Pharmacokinetic modeling and dosage adaptation of biapenem in Japanese patients during continuous venovenous hemodiafiltration, J Infect Chemother, 14, 35, 10.1007/s10156-007-0572-1 Mitomi, 1987, Absorption, distribution, and excretion of arbekacin after intravenous and intramuscular administration in rats, Jpn J Antibiot, 40, 357 Tanikaze, 2004, Study of clinical significance of PK/PD (pharmacokinetic/pharmacodynamic) parameters after administering arbekacin to patients with pulmonary methicillin-resistant Staphylococcus aureus infection, Jpn J Chemother, 52, 469 Mikuniya, 2009, Prevalence of drug resistant gene and changes in susceptibility of methicillin-resistant Staphylococcus aureus strains isolated from 1990 to 2006 in Japan to antimicrobial agents, Jpn J Chemother, 57, 37 Scaglione, 2002, Can PK/PD be used in everyday clinical practice?, Int J Antimicrob Agents, 19, 349, 10.1016/S0924-8579(02)00020-1